Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2400012	ACZ885	canakinumab	Injection	Biological Products(1)	Supplementary Application	2024-02-05		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JXSB2300039	ACZ885注射液	canakinumab	Injection	Biological Products(2.2)	Supplementary Application	2023-04-11		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JXSB2300019	ACZ885	canakinumab	Injection	Biological Products(1)	Supplementary Application	2023-02-21		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JXSL2200063	ACZ885	canakinumab	Injection	Biological Products(2.2)	Import Drug Application	2022-05-26		China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG			view
JXSL2200064	ACZ885	canakinumab	Injection	Biological Products(2.2)	Import Drug Application	2022-05-26		China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG			view
JXSL2100046	ACZ885注射液	canakinumab	Injection	Biological Products(2.2)	Import Drug Application	2021-04-01	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG	In Review	2021-03-31	view
JXSL1800040	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800042	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800041	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800043	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800007	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1800006	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1600020	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2016-04-13	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2017-10-16	view
JXSL1600018	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2016-04-13	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2017-10-16	view
JXSL1100049	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2011-09-30	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2012-06-08	view
JXSL1100010	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2011-03-03	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2012-05-28	view
JXSL0900072	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2009-10-16	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2010-11-23	view